Literature DB >> 1639610

Ethacrynic acid induces reversible shape and cytoskeletal changes in cultured cells.

K Erickson-Lamy1, A Schroeder, D L Epstein.   

Abstract

Cell cultures derived from trabecular meshworks of human and bovine eyes and from bovine vascular endothelia were incubated at 37 degrees C for 1 hr with ethacrynic acid (ECA, 0.1-0.5 mmol/l) dissolved in culture medium. At 2 hr after the initial exposure, ECA at concentrations up to 0.4 mmol/l induced a reversible alteration in cell shape in all three cell types that was coincident with a change in the staining pattern of major cytoskeletal components including actin, alpha-actinin, vinculin, and vimentin. Distinct progressive alterations in beta-tubulin also occurred, with initial changes observed 10 min after ECA exposure. The ECA-induced changes in tubulin were blocked in part by preincubation with taxol (which stabilizes the microtubule structure), but they appeared to differ from those occurring with nocodazole (which interferes with tubulin assembly). These results suggest the possibility that ECA-induced increases in outflow facility may be mediated by alterations in the cytoskeletons of outflow pathway cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639610

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

Review 1.  Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.

Authors:  Megumi Honjo; Hidenobu Tanihara
Journal:  Jpn J Ophthalmol       Date:  2018-02-14       Impact factor: 2.447

Review 2.  Matricellular proteins in the trabecular meshwork: review and update.

Authors:  Ayan Chatterjee; Guadalupe Villarreal; Douglas J Rhee
Journal:  J Ocul Pharmacol Ther       Date:  2014-06-05       Impact factor: 2.671

Review 3.  Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.

Authors:  Ponugoti Vasantha Rao; Padmanabhan P Pattabiraman; Casey Kopczynski
Journal:  Exp Eye Res       Date:  2016-09-01       Impact factor: 3.467

4.  From the bedside to the bench and back again: predicting and improving the outcomes of SLT glaucoma therapy.

Authors:  Jorge A Alvarado; Rumiko Iguchi; Richard Juster; Julie A Chen; Amde Selassie Shifera
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

5.  Characterization of cytoskeleton-enriched protein fraction of the trabecular meshwork and ciliary muscle cells.

Authors:  Toshihiro Inoue; Paula Pecen; Rupalatha Maddala; Nikolai P Skiba; Padmanabhan P Pattabiraman; David L Epstein; P Vasantha Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-14       Impact factor: 4.799

Review 6.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

Review 7.  Pharmacological advances in the treatment of glaucoma.

Authors:  J B Serle
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

8.  Eyedrops containing SA9000 prodrugs result in sustained reductions in intraocular pressure in rabbits.

Authors:  John J Arnold; Yash Choksi; Xin Chen; Atsushi Shimazaki; John Hatten; Eric J Toone; David L Epstein; Pratap Challa
Journal:  J Ocul Pharmacol Ther       Date:  2009-06       Impact factor: 2.671

Review 9.  The role of the actomyosin system in regulating trabecular fluid outflow.

Authors:  Baohe Tian; B'Ann T Gabelt; Benjamin Geiger; Paul L Kaufman
Journal:  Exp Eye Res       Date:  2008-08-27       Impact factor: 3.467

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.